TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Former DCRRC Chief Saunders Proposes Total Separation Of NCI Intramural, Extramural Research February 10, 1978
TCL Archive Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs September 7, 1990
TCL Archive HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing November 19, 1993
